NIH Funding · FY2024
Total Funding
$2.1M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#5,011
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $2.1M across 4 grants · National rank #5011.
Top grants by award amount
Richard D Kolodner's NIH grant portfolio, ranked by award amount.
- 5R01CA255341-04R01FEN1 Endonuclease as a Synthetic Lethal Target for Cancer Therapy$607.5Kaward amount
- 5R01CA251414-04R01FEN1-Nuclease-Targeted Therapy for Ewing Sarcoma$593.1Kaward amount
- $463.6Kaward amount
- $406.9Kaward amount
Affiliation
Institutions that have administered grants for Richard D Kolodner.
Affiliated with University of California, San Diego (CA).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardUniversity of California, San Diego
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #5011
Related investigators
Other NIH-funded PIs frequently associated with Richard D Kolodner.
Bing Ren
10 grants
$25.9M
total funding
Ed Lein
8 grants
$21.8M
total funding
Dennis R. Burton
2 grants
$21M
total funding
Christina Chambers
9 grants
$19.6M
total funding
Joseph R Ecker
2 grants
$17.9M
total funding
Ting Wang
11 grants
$17.6M
total funding
Anders M Dale
5 grants
$16.5M
total funding
Orlando M Gutierrez
7 grants
$14.6M
total funding
Paul M Thompson
12 grants
$12.7M
total funding
Charles Alexander Nelson
7 grants
$12.5M
total funding
Explore further
Find collaborators for Richard D Kolodner
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at University of California, San Diego
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →